Nutrien (NTR)
(Delayed Data from NYSE)
$44.47 USD
-0.11 (-0.25%)
Updated Dec 23, 2024 04:00 PM ET
After-Market: $44.37 -0.10 (-0.22%) 7:58 PM ET
5-Strong Sell of 5 5
C Value F Growth C Momentum D VGM
Price, Consensus and EPS Surprise
NTR 44.47 -0.11(-0.25%)
Will NTR be a Portfolio Killer in December?
Zacks Investment Research is releasing its prediction for NTR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NTR
El Pollo Loco and Nutrien have been highlighted as Zacks Bull and Bear of the Day
Bear of the Day: Nutrien (NTR)
NTR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Nutrien (NTR) Down 1.8% Since Last Earnings Report: Can It Rebound?
Nutrien's Q3 Earnings and Revenues Fall Short of Estimates
Nutrien (NTR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for NTR
Yearly Portfolio Review - November Dividend Income Report
Nutrien Enters Oversold Territory
Brazil Potash appoints Mayo Schmidt new executive chairman
Brazil Potash appoints Mayo Schmidt new executive chairman
CF Industries Holdings, Nutrien rated Outperform in new coverage at Oppenheimer